Financials
Financial year 2025
SMI from Sankt Vith, company number BE0432408182, closed financial year 2025 with a result of € 10.2 million after tax. For that financial year SMI recorded revenue of € 35 million and equity of € 14 million. Compared with financial year 2024, the result moved from € 10 million to € 10.2 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.
€ 14 million
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10.2 million
▲ 2% vs 2024
Profit after tax over the fiscal year.
€ 10.7 million
▼ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 10 million paid out
99 % of the profit went to the shareholders, mostly to MAS A.G. (100 % of the shares). That is where the money ends up.
People and assets in 2025
12.9
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 499,617
▲ 2% vs 2024
€ 38,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 6,360
▼ 48% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.3 million
▲ 35% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 23 days on average.
€ 458,698
▼ 45% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 33,987,977 | € 33,513,553 | € 36,911,514 | € 35,008,749 | ▼ 5% |
| Profit after taxes | € 9,963,762 | € 7,849,711 | € 9,955,142 | € 10,151,326 | ▲ 2% |
| Equity | € 41,060,954 | € 48,910,665 | € 13,865,807 | € 14,017,132 | ▲ 1% |
| Total debts | € 871,178 | € 1,442,799 | € 18,650,993 | € 11,752,592 | ▼ 37% |
| Cash | € 24,695,579 | € 35,613,331 | € 17,585,846 | € 10,657,104 | ▼ 39% |
| Land & buildings | € 402,882 | € 313,636 | € 262,311 | € 248,823 | ▼ 5% |
| Retained profit | € 39,990,954 | € 47,840,665 | € 12,795,807 | € 12,947,132 | ▲ 1% |
| Dividend | € 0 | € 0 | € 45,000,000 | € 10,000,000 | ▼ 78% |
| Balance sheet total | € 41,932,131 | € 50,353,464 | € 32,516,800 | € 25,769,724 | ▼ 21% |
| Employees (FTE) | 14.5 | 13.8 | 12.8 | 12.9 | ▲ 0.1 |
Key figures of SMI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SMI?
What happened at SMI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 10.2 million (▲ 2% vs 2024). filed late Source: NBB ↗
- New establishment in Sankt Vith. KBO
- Start of the company according to the CBE. KBO
In short
From € 10 million profit in 2022 to € 10.2 million profit in 2025.
Paid € 12.3 million in corporate taxes since 2022.
Best year ever: 2025, with € 10.2 million profit.
Paid out € 55 million in dividends to the owners in total.
A new publication or filing at SMI? We notify you, reason included.
Follow SMIDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MAS A.G. comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
SMIBehind SMI are Raymund SCHMITZ, Anneliese MICHAELIS and André SCHMITZ. The shares are held by MAS A.G. (99.5%).
Directors
According to the 2025 annual accounts
Raymund SCHMITZ
Director
Anneliese MICHAELIS
Director
André SCHMITZ
Director
Shareholders
99.5%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Steinerberg 8
4780 Sankt Vith
Stechelsberg,Hünningen 13
4780 Sankt Vith
Active since 2 December 1987
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
SAARGATE-AS VSE NET GmbH, DE
Website info
Features
Security
Details
- Company number
- 0432.408.182
- VAT number
- BE 0432.408.182
- Registered office
- Steinerberg 8, 4780 Sankt Vith
- Names & denominations
- SMI
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 November 1987
- Peppol
- Active · Active since 30 Dec 2025
- Contact
- sutures.be [email protected] 080227292
- Activities · NACE
Vervaardiging van geneesmiddelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Vervaardiging van niet-elektrische apparaten en instrumenten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde